Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul;50(7):798-804.
doi: 10.1111/imj.14889.

Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty

Al-Ani Aysha  1 , Clarissa Rentsch  1 , Ralley Prentice  1 , Doug Johnson  2 , Robert V Bryant  3   4 , Mark G Ward  5   6 , Samuel P Costello  3   4 , Peter Lewindon  7 , Simon Ghaly  8 , Susan J Connor  9   10   11 , Jakob Begun  12   13 , Britt Christensen  1   5
Affiliations
Review

Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty

Al-Ani Aysha et al. Intern Med J. 2020 Jul.

Abstract

The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has emerged as a public health emergency and challenged healthcare systems globally. In a minority of patients, SARS-CoV-2 manifests with a severe acute respiratory illness and currently there is insufficient data regarding the virulence of COVID-19 in inflammatory bowel disease patients taking immunosuppressive therapy. This review aims to summarise the current literature and provide guidance on the management of inflammatory bowel disease patients in the context of the COVID-19 pandemic in the Australasian setting.

Keywords: COVID-19; Crohn disease; SARS-CoV-2; immunosuppression; inflammatory bowel disease; ulcerative colitis.

PubMed Disclaimer

References

    1. Kang L, Li Y, Hu S, Chen M, Yang C, Yang BX et al The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus. Lancet Psychiatry 2020; 7: e14. - PMC - PubMed
    1. Al‐Ani A, Prentice R, Rentsch C, Johnson D, Ardalan Z, Heerasing N et al Review article: prevention, diagnosis and managment of COVID‐19 in the IBD patient. Aliment Pharmacol Ther 2020; 52: 54–72. - PMC - PubMed
    1. Hoffmann M, Kleine‐Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S et al SARS‐CoV‐2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020; 181: 271–80.e8. - PMC - PubMed
    1. Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID‐19 and the possibility of faecal transmission. Aliment Pharmacol Ther 2020; 51: 843–51. - PMC - PubMed
    1. Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J et al Clinical characteristics of COVID‐19 patients with digestive symptoms in Hubei, China: a descriptive, cross‐sectional, multicenter study. Am J Gastroenterol 2020; 115: 766–73 - PMC - PubMed

MeSH terms

Substances